
Overview of results
Adjusted earnings increased by £38 million or +41% (2024: +£2 million
or +2.4%) to £131 million (2024: £93 million). The significant increase
reflects just under five months of additional income arising from
the combination with Assura portfolio along with the solid
performance of the underlying portfolio driven by organic growth
from rent reviews and asset management activity in the year. Using
the weighted average number of shares in issue in the year, the
adjusted earnings per share increased to 7.3 pence
(2024: 7.0 pence), an increase of 4.3% (2024: +2.9%).
A revaluation surplus of £48 million (2024: deficit of £38 million)
was generated in the year from the portfolio, equivalent to 2 pence
(2024: deficit of 3 pence) per share.
Profit after tax as reported under IFRS rose to £119 million
(2024: £41 million).
EPRA NTA reduced by 4% to 99 pence per share (31 December
2024: 103 pence). The combination with Assura impacted the EPRA
NTA by 6 pence per share, reflecting the effects of the share
exchange ratio and transaction costs incurred. On an underlying
basis, a 2 pence per share uplift was delivered from the positive
portfolio revaluation. Including the MtM benefit of fixed rate debt
of 5 pence per share, Adjusted NTA stands at 104 pence.
The Group’s balance sheet remains robust, with significant liquidity
headroom, with cash and collateralised undrawn loan facilities,
after capital commitments, totalling £571 million (31 December 2024:
£271 million). The loan to value ratio of 57% (31 December 2024:
48%) is currently higher than our targeted range of between 40%
and 50%, as a result of the combination with Assura, but as noted
above, we have a clear plan to bring this back within the targeted
range during 2026.
Dividends
The Company distributed a total of 7.1 pence per share in 2025
which was fully covered, an increase of 2.9% over the 2024
dividend of 6.9 pence per share. The total value of dividends
distributed in the year increased by 27% to £117 million (2024:
£92 million), which were fully covered by adjusted earnings. During
2025, the scrip dividend scheme continued to be suspended as a
consequence of the ongoing weakness in the share price and a
Dividend Reinvestment Plan continued to be offered in its place.
The first interim dividend of 1.825 pence per share, equivalent to
7.3 pence on an annualised basis, an increase of 2.8% over the 2025
rate, was paid on 13 March 2026 and the second is payable on 8
May 2026 to shareholders on the register at 27 March 2026.Both
dividends represent a Property Income Distribution of 1.325 pence
and an ordinary dividend of 0.5 pence.
The Company intends to maintain its strategy of paying a
progressive dividend, paid in equal quarterly instalments, that
is covered by adjusted earnings in each financial year. Further
dividend payments are planned to be made on a quarterly basis
in May, August and November 2026 which are expected to
comprise a mixture of both Property Income Distribution and
normal dividend. It is proposed that authority will be sought at
the AGM for the re-introduction of the scrip dividend for future
dividends, at the Directors’ discretion.
Board changes
We were delighted to welcome Jonathan Davies to the Board
following his appointment as an independent Non-executive
Director effective from 1 December 2025. Jonathan brings a deep
understanding of the sector and Assura’s business, having served
as its Senior Independent Director and, latterly, Chair, providing the
Company’s stakeholders with continuity during the integration
period and beyond.
Johannesburg Stock Exchange (“JSE”)
secondary listing
During the year, the Company continued to build on the growing
interest in the Company and its profile in the South African market,
where investors have shown strong interest in the combination with
Assura and the Group’s unique healthcare property investment
opportunity. Since joining the JSE in October 2023, the secondary
listing has helped contribute to liquidity in the Group’s shares and
as at 31 December 2025, approximately 49 million shares or 2%
(31 December 2024: 14 million or 1%) of the register is now listed
on the JSE. We continue to help potential South African investors
acquire PHP shares and provide further liquidity on the JSE with
the objective of increasing the number of shares listed there to
between 5% and 10% of the Group’s total issued share capital.
Environmental, Social and Governance (“ESG”)
PHP has a strong commitment to responsible business and ESG
matters are at the forefront of the Board’s and our various
stakeholders’ considerations. PHP published in 2022 a Net Zero
Carbon (“NZC”) Framework setting out the five key steps we are
taking to achieve a target of being NZC by 2030. However, the
combination with Assura and significant increase in the scale of the
portfolio means now is the right time to review appropriate targets.
Consequently, we will revisit both PHP’s NZC Framework and
Assura’s NZC Pathway, including Science Based Targets initiative
targets, over the course of 2026.
During 2025, we continued to progress the delivery of our original
NZC Framework achieving net zero operations for the third year in
succession and the Group completed three NZC developments at
Croft, West Sussex; South Kilburn, London; and an NHS children’s
therapy centre at Fareham, Hampshire.
We continue to modernise existing buildings and improve the
environmental credentials of our portfolio through the asset
management programme. As at 31 December 2025, 63% of assets
have an EPC rating of A or B (31 December 2024: 47%) and 93%
at A to C (31 December 2024: 88%).
As a leading provider of modern primary care premises, we aim to
create a lasting positive social impact, particularly on the health
outcomes and wellbeing in the communities where we are invested.
We believe that our activities benefit not only our shareholders but
also our wider stakeholders, including occupiers, patients, the NHS
and HSE, suppliers, lenders and the wider communities in both the
UK and Ireland.
Further details on our progress in the year, objectives for the future
and approach to responsible business can be found in
our Responsible Business Report.
Chair’s statement continued
Primary Health Properties PLC Annual Report 2025
12
Strategic report Governance Financial statements Shareholder information